.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Johnson and Johnson
Merck
Federal Trade Commission
Harvard Business School
Argus Health
McKesson
Express Scripts
Chubb
Fuji

Generated: June 23, 2017

DrugPatentWatch Database Preview

TRILITRON Drug Profile

« Back to Dashboard

What is the patent landscape for Trilitron, and what generic Trilitron alternatives are available?

Trilitron is a drug marketed by Newtron Pharms and is included in two NDAs.

The generic ingredient in TRILITRON is pseudoephedrine hydrochloride; triprolidine hydrochloride. There are forty-nine drug master file entries for this compound. Additional details are available on the pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.

Summary for Tradename: TRILITRON

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list11
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TRILITRON at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Newtron Pharms
TRILITRON
pseudoephedrine hydrochloride; triprolidine hydrochloride
TABLET;ORAL088515-001Jan 9, 1985DISCNNoNo► Subscribe► Subscribe
Newtron Pharms
TRILITRON
pseudoephedrine hydrochloride; triprolidine hydrochloride
SYRUP;ORAL088474-001Feb 12, 1985DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Fuji
Healthtrust
Fish and Richardson
Federal Trade Commission
Colorcon
Cantor Fitzgerald
Baxter
QuintilesIMS
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot